Trial Profile
NIS Xeloda in Gastric Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2014
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Roche
- 28 Oct 2014 New trial record